SEC 13F Intelligence

Bridge City Capital, LLC / HAE

Bridge City Capital, LLC’s Haemonetics Corp Mass Position

Does Bridge City Capital, LLC own Haemonetics Corp Mass (HAE)? Not currently — the last reported position was 48.0K shares worth $5M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q1 2021
Shares
48.0K
% of Portfolio
+1.77%
Quarters Held
10
position exited

Position History HAE

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $4MQ2 ’19Q3 ’19: $5MQ4 ’19: $5MQ4 ’19Q1 ’20: $5MQ2 ’20: $4MQ2 ’20Q3 ’20: $4MQ4 ’20: $6MQ4 ’20Q1 ’21: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202148.0K$5M+1.77%
Q4 202048.5K$6M+2.19%
Q3 202049.0K$4M+2.04%
Q2 202040.6K$4M+1.67%
Q1 202046.6K$5M+2.25%
Q4 201940.5K$5M+1.92%
Q3 201940.5K$5M+2.20%
Q2 201931.8K$4M+2.10%
Q1 201931.6K$3M+1.61%
Q4 201831.9K$3M+2.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridge City Capital, LLC’s full portfolio or all institutional holders of HAE.